New project receives $ 9 million CIHR funding to monitor global threat of COVID-19 modifications

A researcher-led project at the University’s Ottawa Faculty of Science has awarded $ 9 million in Canadian Institutes of Health Research (CIHR) funding to create a national network for better research and response to global risk there are COVID-19 differences.

Directed by Dr. Marc-Andre Langlois, Coronavirus Variants Rapid Response Network or CoVaRR-Net, allows a real-time assessment of both the immune response to the virus variants and whether these changes are resistant to the existing vaccines. The findings will guide decision-makers regarding drug treatment, vaccine efficacy, and other public health strategies.

CoVaRR-Net is poised to contribute to Canada’s effort to reduce the impact of harmful differences (VOCs) on Canadian citizens and the global population. This project includes a co-ordinated and rapid approach to real-time assessment of the potential risk of SARS-CoV-2 changes and will be a plan for future pandemics. come to protect the health of all Canadians. This network will serve as Canada’s unified platform for determining how VOCs affect Canadians from diverse communities and demographics and for monitoring the uptake of SARS-CoV-2 going around in real time. “

Dr. Langlois, Canadian Research Chair in Molecular Epidemiology and Intrauterine Immunology and full Professor in the Department of Biochemistry, Microbiology, and Immunology at the University of Ottawa

Dr. will. Langlois and his team collaborate with the National Microbiology Laboratory (NML) of the Canadian Public Health Agency, the Canadian COVID-19 Genomics Network (CanCOGeN), regional and territorial public health laboratories, and national and international organizations other.

The project is supported by a number of uOttawa partners, including:

  • Amy Hsu, Associate Professor in the Department of Family Medicine and Researcher at the Bruyère Research Institute;
  • Angela Crawley, Associate Professor in the Faculty of Medical Sciences and scientist at Ottawa Hospital (TOH);
  • Melissa Brouwers, Director of the Ottawa School of Epidemiology and Public Health;
  • Jeremy Grimshaw, Professor in the Department of Medicine and Chief Scientist at TOH;
  • Doug Manuel, Professor in the Faculty of Family Studies and Senior Specialist at TOH;
  • Justin Presseau, Associate Professor at uOttawa and Senior Scientist at TOH.

CoVaRR-Net members and research partners include:

  • Bruyère Research Institute
  • Ottawa Hospital
  • Université de Montréal
  • Dalhousie University
  • University of Calgary
  • Université Laval
  • Sinaï Health System
  • University of Toronto
  • University of Saskatchewan
  • McGill University
  • University of British Columbia
  • Simon Fraser University
  • University of Regina
  • SPOR (Patient Research Strategy)
  • Saskatchewan Health Authority